drugset

drugset / Trial / NCT00793585

A Controlled Study of Uric Acid on the Progression of IgA Nephropathy

NCT00793585 ↗

Completed 40 enrolled Sun Yat-sen University

RandomizedParallel-groupOpen-labelTreatment

Summary

This prospective, randomized controlled study will evaluate the effect of uric acid on the progression of IgA nephropathy.

Timeline

Start: 2007-07
Primary completion: 2009-06
Completion: 2009-06

Publications

Tunnicliffe DJ, Reid S, Craig JC, Samuels JA, Molony DA, Strippoli GF. Non-immunosuppressive treatment for IgA nephropathy. Cochrane Database Syst Rev. 2024 Feb 1;2(2):CD003962. doi: 10.1002/14651858.CD003962.pub3.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Allopurinol	Small molecule	200 mg	—

Indications